Renesas Electronics vs a2z Radiology AI

Side-by-side comparison of AI visibility scores, market position, and capabilities

Renesas Electronics

LeaderSemiconductors & Hardware

Automotive & Industrial Microcontrollers

Japanese MCU giant formed from Hitachi/NEC/Mitsubishi semiconductor units; global #1 in automotive MCUs. Acquired Dialog, Integrated Device Technology, and Celonics to diversify.

About

Renesas Electronics was formed in 2003 through the merger of semiconductor operations from Hitachi, NEC, and Mitsubishi Electric, and listed on the Tokyo Stock Exchange in 2014. The company is the world's largest supplier of automotive microcontrollers (MCUs) and a leading provider of mixed-signal, power management, and embedded processing semiconductors for automotive, industrial, IoT, and infrastructure applications.\n\nRenesas' automotive MCU portfolio—including the RH850 and RH series—is embedded in virtually every major car manufacturer's vehicle control units, covering engine management, chassis control, body electronics, and ADAS. The company has executed an aggressive M&A strategy to diversify away from automotive cyclicality: acquiring Intersil (2017, analog/power), Integrated Device Technology (2019, timing/memory interface), Dialog Semiconductor (2021, connectivity/power management), and Celonics (2024). These acquisitions have built out Renesas' capabilities in Bluetooth, Wi-Fi, USB, and power conversion.\n\nRenesas generated approximately ¥1.4 trillion (approximately $9 billion) in annual revenue and faces near-term headwinds from automotive inventory normalization and weaker EV demand in China. The company is investing in next-generation R-Car SoCs for software-defined vehicles, ADAS, and autonomous driving, and recently announced collaboration with TSMC for advanced process node production.

Full profile

a2z Radiology AI

EmergingEnterprise AI

Medical Imaging AI

a2z Radiology AI raised $20M in 2025 for its whole-body AI that simultaneously screens for 24+ conditions across CT scans — from incidental cancers to cardiovascular risk — in a single automated read.

About

a2z Radiology AI has developed a whole-body CT analysis platform that simultaneously screens for over 24 medical conditions across a single CT scan, including incidental cancers, coronary artery disease, aortic aneurysm, bone density loss, and organ abnormalities. The AI acts as a second reader that radiologists can use to catch incidental findings that fall outside the primary reason for a scan — a major source of missed diagnoses.

Full profile

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.